期刊文献+

急性心肌梗死临床治疗分析 被引量:7

Analysis Clinical Treatment of Acute Myocardial Infarction
下载PDF
导出
摘要 目的:分析急性心肌梗死的临床治疗方法及效果。方法选取2014年3月~2015年3月我院接收的急性心肌梗死患者123例,按照不同的治疗方法分为对照组与实验组。对照组60例使用常规药物治疗,实验组63例在常规药物基础上联合溶栓治疗方法进行治疗,比较两组患者的治疗效果。结果实验组的治疗效果优于对照组,P<0.05,差异具有统计学意义。结论在常规药物治疗的基础上联合溶栓治疗法在治疗急性心肌梗死方面,具有良好效果,且并发症较少。 Objective Analysis the clinical therapeutic method and effect of acute myocardial infarction.MethodsSelected 123 patients with acute myocardial infarction received from March 2014 to March 2015 in our hospital were divided into the control group and the experimental group, according to different treatment methods, the control group had 60 cases were treated with conventional drugs, and the experimental group had 63 cases were treated with the combined therapy based on conventional drugs. compared the therapeutic effect of two groups.ResultsThe treatment effect of the experimental group was better than the control group,P〈0.05, had difference statistically significance.Conclusion In treatment of patients with acute myocardial infarction, the combine treatment with thrombolytic therapy based on conventional drug therapy has obvious effect, and the complications are less.
作者 袁清茹
出处 《中国继续医学教育》 2015年第26期84-85,共2页 China Continuing Medical Education
关键词 急性心肌梗死 溶栓 Acute myocardial infarction Thrombolysis
  • 相关文献

参考文献4

二级参考文献49

  • 1李蓉,袁祖贻.早期他汀类药物治疗对急性心肌梗死患者的益处[J].实用医技杂志,2007,14(9):1102-1103. 被引量:5
  • 2于兆安,于首元,于峰.硝苯地平控释片对急性心肌梗死缺血-再灌注损伤的保护作用[J].上海医药,2005,26(5):233-234. 被引量:1
  • 3贾浩.急性心肌梗死不同时期溶栓的疗效观察和分析[J].临床医学,2006,26(10):66-67. 被引量:10
  • 4盛净,娄金荣,蔡文玮.ACEI对急性心肌梗死溶栓治疗时胰岛素敏感性的影响[J].上海交通大学学报(医学版),2006,26(11):1252-1255. 被引量:1
  • 5Orso F, Maggioni AP. What is the optimal reperfusion strategy for elderly pa- tients with acute MI[J] ? Am J Geriatr Cardiol, 2006, 15:14-18.
  • 6Cleland JG, Caletta AP, Freemantle N, et al. Clinical trials update from the A- merican College of Cardiology meeting: CARE-HF and the remission of heart failure, Women's Health Study, TNT, COMPASS-HF, VERITAS, CANPAP, PEECH and PREMIER[J]. Eur J Heart Fail, 2005, 7:931-936.
  • 7Moser M, Bode C. Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction [ J ]. Expert Opin Investig Drugs, 1999, 8 : 329- 335.
  • 8Moser M, Kohler B, Schmitmer M, et al. Recombinant plasminogen activators:a comparative review of the clinical pharmacology and therapeutic use of alteplase and reteplase[J]. BioDrugs, 1998, 9:455-463.
  • 9Stepitska J, Sadowski Z, Szajewski T, et al. Calcium blocker therapy before myocardial infarction increases post-infarction short-and long-term mortality. Da- ta from the INJECT trial[J]. Kardiol Pal, 2002, 57:512-519.
  • 10VanI Hof AW, Ten Berg J, Heestermans T, et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty ( On-TIME 2 ) : a muhicentre, double-blind, randomised controlled trial[J]. Lancet, 2008, 372: 537-546.

共引文献77

同被引文献36

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部